Cargando…
Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants
Vaccines are considered to be one of the most significant medical interventions against infectious diseases. Despite this success, major obstacles remain in developing vaccines for pathogens against which vaccines do not exist or against emerging pathogens and improving suboptimal vaccines. Key elem...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404728/ http://dx.doi.org/10.1016/B978-012088403-2/50005-8 |
_version_ | 1783567177262039040 |
---|---|
author | Pashine, Achal Ulmer, Jeffrey B. Valiante, Nicholas M. |
author_facet | Pashine, Achal Ulmer, Jeffrey B. Valiante, Nicholas M. |
author_sort | Pashine, Achal |
collection | PubMed |
description | Vaccines are considered to be one of the most significant medical interventions against infectious diseases. Despite this success, major obstacles remain in developing vaccines for pathogens against which vaccines do not exist or against emerging pathogens and improving suboptimal vaccines. Key elements needed to design effective vaccines include identification of protective antigens against which a robust and durable adaptive response must be generated, compounds that can stimulate the innate immune responses, and optimal delivery systems which carry and dispense the antigenic and immuno stimulatory cargo to the appropriate cells of the immune system. The mechanistic understanding and the tools to manipulate this system are growing and it is likely that novel immune potentiators and delivery systems can make a significant impact on vaccine development in the near future. Thus, selecting the optimal platforms for development and identifying the key cellular and molecular targets of the innate immune system can trigger the safest and most effective immune responses against diverse pathogens which should be the long-term goal. |
format | Online Article Text |
id | pubmed-7404728 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
record_format | MEDLINE/PubMed |
spelling | pubmed-74047282020-08-05 Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants Pashine, Achal Ulmer, Jeffrey B. Valiante, Nicholas M. Immunopotentiators in Modern Vaccines Article Vaccines are considered to be one of the most significant medical interventions against infectious diseases. Despite this success, major obstacles remain in developing vaccines for pathogens against which vaccines do not exist or against emerging pathogens and improving suboptimal vaccines. Key elements needed to design effective vaccines include identification of protective antigens against which a robust and durable adaptive response must be generated, compounds that can stimulate the innate immune responses, and optimal delivery systems which carry and dispense the antigenic and immuno stimulatory cargo to the appropriate cells of the immune system. The mechanistic understanding and the tools to manipulate this system are growing and it is likely that novel immune potentiators and delivery systems can make a significant impact on vaccine development in the near future. Thus, selecting the optimal platforms for development and identifying the key cellular and molecular targets of the innate immune system can trigger the safest and most effective immune responses against diverse pathogens which should be the long-term goal. 2006 2007-05-09 /pmc/articles/PMC7404728/ http://dx.doi.org/10.1016/B978-012088403-2/50005-8 Text en Copyright © 2006 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Pashine, Achal Ulmer, Jeffrey B. Valiante, Nicholas M. Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants |
title | Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants |
title_full | Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants |
title_fullStr | Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants |
title_full_unstemmed | Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants |
title_short | Innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants |
title_sort | innate immune mechanisms and the identification of immune potentiators as vaccine adjuvants |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404728/ http://dx.doi.org/10.1016/B978-012088403-2/50005-8 |
work_keys_str_mv | AT pashineachal innateimmunemechanismsandtheidentificationofimmunepotentiatorsasvaccineadjuvants AT ulmerjeffreyb innateimmunemechanismsandtheidentificationofimmunepotentiatorsasvaccineadjuvants AT valiantenicholasm innateimmunemechanismsandtheidentificationofimmunepotentiatorsasvaccineadjuvants |